This Center focuses on developing new treatments for neurodegenerative disorders, mental health and neuromuscular disorders.
2025 ADDF-Harrington Invitation for Proposals
2022 and 2023 ADDF-Harrington Scholars Announced
Challenging the Status Quo in the Fight Against Alzheimer's Disease
Harrington Discovery Institute’s Pursuit of Performance Medicine
Looking at Alzheimer's Differently
Linda and Les Vinney Scholars
Director, Center for Brain Health Medicines at Harrington Discovery Institute; Morley-Mather Chair in Neuropsychiatry; Professor of Psychiatry, Case Western Reserve University; Psychiatrist, Louis Stokes VA Medical Center of Cleveland
Alzheimer’s disease is the most common form of dementia worldwide, and causes loss of cognitive function that steadily and progressively impairs all aspects of normal daily living. Its impact is devastating for families and communities. Despite its discovery well over a century ago, there are still no effective treatments for patients with Alzheimer’s disease.
Combating this major unmet need requires innovative approaches to discovery and development of new medicines that will prevent, slow, halt, or reverse the disease. At the Center for Brain Health Medicines at Harrington Discovery Institute, we are pursuing this goal through our scholar pipeline to attack the disease from multiple angles, focusing specifically on projects with potential to enter into formal clinical development within 1–2 years.
Andrew Pieper, MD, PhD
Director, Center for Brain Health Medicines
